Natural 10mg 25mg Empagliflozin drug raw Materials Powder

Related Attributes

Product details

Empagliflozin Powder Usage and Synthesis.

Epalliprazin is indicated for the treatment of adults with diabetes who do not achieve adequate glycemic control with diet combined with exercise to improve glycemic control. It should not be used to treat patients with type 1 diabetes, elevated ketones in the blood or urine (diabetic ketoacidosis), severe kidney damage, end-stage kidney disease, and dialysis.

Empagliflozin vs. Other Diabetes Medications

Medication Class	Key Benefit	Best For
SGLT2 Inhibitors (Empagliflozin)	Heart & kidney protection	Diabetics with CVD/CKD
GLP-1 Agonists (Semaglutide)	Weight loss & HbA1c control	Obesity + diabetes
Metformin	First-line, low-cost	Early-stage diabetes
Insulin	Direct blood sugar control	Type 1 or advanced type 2

Pharmacological action of Empagliflozin.

Under physiological environment, the kidney filters and reabsorbs glucose into the circulatory system to maintain the blood glucose balance in the body, while glucose enters the blood through the renal tubule lumen with the cooperation of glucose cotransport protein. SGLT2, as a form of sodium and glucose cotransport protein in glucose cotransport protein, blocks the reabsorption of glucose by the proximal convoluted tubules. Reduces glucose reabsorption by the kidneys and increases the excretion of glucose in the urine, thereby reducing plasma glucose levels. The hypoglycemic effect did not depend on the function of beta cells and was not affected by insulin resistance